Product Program year 2019 Source: CMS Open Payments

Farydak

Drug Oncology

NDC 0078-0651-06

Open in the dashboard

General payments

$148,035

598 payments

Research payments

$74,079

1 payment

Through program year 2019, $148,035 in general payments and $74,079 in research payments were reported against Farydak (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $148,035 598
2019 Research $74,079 1

Breakdown

Who paid General payments · program year 2019
  1. Secura Bio, Inc. $148,035 598 payments
Top recipients General payments · program year 2019
  1. Kashyap Patel Hematology & Oncology · Rock Hill, SC $48,615 33% · 21 payments
  2. Ralph Boccia Hematology & Oncology · Bethesda, MD $33,414 23% · 8 payments
  3. Paul Richardson Hematology & Oncology · Boston, MA $6,330 4% · 2 payments
  4. Han Myint Medical Oncology · Aurora, CO $3,868 3% · 2 payments
  5. Asutosh Gor Hematology & Oncology · Rock Hill, SC $3,038 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $126,416 86% · 300 practitioners
  2. Medical Oncology Internal Medicine $16,021 11% · 83 practitioners
  3. Hematology Internal Medicine $3,811 3% · 9 practitioners
  4. Internal Medicine $546 <1% · 13 practitioners
  5. Pediatric Hematology-Oncology Pediatrics $509 <1% · 2 practitioners

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. South Carolina $58,604 40% · 27 recipients
  2. Maryland $33,514 23% · 7 recipients
  3. Massachusetts $7,527 5% · 5 recipients
  4. New York $6,142 4% · 19 recipients
  5. California $4,488 3% · 75 recipients

The top 5 of 35 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

598 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record